A citation-based method for searching scientific literature

Jörg B Schulz, Sylvia Boesch, Katrin Bürk, Alexandra Dürr, Paola Giunti, Caterina Mariotti, Francoise Pousset, Ludger Schöls, Pierre Vankan, Massimo Pandolfo. Nat Rev Neurol 2009
Times Cited: 158







List of co-cited articles
611 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Friedreich's ataxia: autosomal recessive disease caused by an intronic GAA triplet repeat expansion.
V Campuzano, L Montermini, M D Moltò, L Pianese, M Cossée, F Cavalcanti, E Monros, F Rodius, F Duclos, A Monticelli,[...]. Science 1996
48

Clinical and genetic abnormalities in patients with Friedreich's ataxia.
A Dürr, M Cossee, Y Agid, V Campuzano, C Mignard, C Penet, J L Mandel, A Brice, M Koenig. N Engl J Med 1996
726
34

Friedreich ataxia: the clinical picture.
Massimo Pandolfo. J Neurol 2009
253
22


Histone deacetylase inhibitors reverse gene silencing in Friedreich's ataxia.
David Herman, Kai Jenssen, Ryan Burnett, Elisabetta Soragni, Susan L Perlman, Joel M Gottesfeld. Nat Chem Biol 2006
312
18

The Friedreich ataxia GAA repeat expansion mutation induces comparable epigenetic changes in human and transgenic mouse brain and heart tissues.
Sahar Al-Mahdawi, Ricardo Mouro Pinto, Ozama Ismail, Dhaval Varshney, Stefania Lymperi, Chiranjeevi Sandi, Daniah Trabzuni, Mark Pook. Hum Mol Genet 2008
181
16


Friedreich ataxia: molecular mechanisms, redox considerations, and therapeutic opportunities.
Renata Santos, Sophie Lefevre, Dominika Sliwa, Alexandra Seguin, Jean-Michel Camadro, Emmanuel Lesuisse. Antioxid Redox Signal 2010
122
14

Mortality in Friedreich ataxia.
Amy Y Tsou, Erin K Paulsen, Sarah J Lagedrost, Susan L Perlman, Katherine D Mathews, George R Wilmot, Bernard Ravina, Arnulf H Koeppen, David R Lynch. J Neurol Sci 2011
159
14

Biological and clinical characteristics of the European Friedreich's Ataxia Consortium for Translational Studies (EFACTS) cohort: a cross-sectional analysis of baseline data.
Kathrin Reetz, Imis Dogan, Ana S Costa, Manuel Dafotakis, Kathrin Fedosov, Paola Giunti, Michael H Parkinson, Mary G Sweeney, Caterina Mariotti, Marta Panzeri,[...]. Lancet Neurol 2015
105
14

Scale for the assessment and rating of ataxia: development of a new clinical scale.
T Schmitz-Hübsch, S Tezenas du Montcel, L Baliko, J Berciano, S Boesch, C Depondt, P Giunti, C Globas, J Infante, J-S Kang,[...]. Neurology 2006
13

DNA triplet repeats mediate heterochromatin-protein-1-sensitive variegated gene silencing.
Alexander Saveliev, Christopher Everett, Tammy Sharpe, Zoë Webster, Richard Festenstein. Nature 2003
195
13

Repeat-induced epigenetic changes in intron 1 of the frataxin gene and its consequences in Friedreich ataxia.
Eriko Greene, Lata Mahishi, Ali Entezam, Daman Kumari, Karen Usdin. Nucleic Acids Res 2007
147
13


Frataxin is reduced in Friedreich ataxia patients and is associated with mitochondrial membranes.
V Campuzano, L Montermini, Y Lutz, L Cova, C Hindelang, S Jiralerspong, Y Trottier, S J Kish, B Faucheux, P Trouillas,[...]. Hum Mol Genet 1997
555
13

Measuring Friedreich ataxia: Interrater reliability of a neurologic rating scale.
S H Subramony, W May, D Lynch, C Gomez, K Fischbeck, M Hallett, P Taylor, R Wilson, T Ashizawa. Neurology 2005
208
12

A phase 3, double-blind, placebo-controlled trial of idebenone in friedreich ataxia.
David R Lynch, Susan L Perlman, Thomas Meier. Arch Neurol 2010
125
12

Neurological effects of high-dose idebenone in patients with Friedreich's ataxia: a randomised, placebo-controlled trial.
Nicholas A Di Prospero, Angela Baker, Neal Jeffries, Kenneth H Fischbeck. Lancet Neurol 2007
191
12

GAA repeat expansion mutation mouse models of Friedreich ataxia exhibit oxidative stress leading to progressive neuronal and cardiac pathology.
Sahar Al-Mahdawi, Ricardo Mouro Pinto, Dhaval Varshney, Lorraine Lawrence, Margaret B Lowrie, Sian Hughes, Zoe Webster, Julian Blake, J Mark Cooper, Rosalind King,[...]. Genomics 2006
160
11

Clinical, biochemical and molecular genetic correlations in Friedreich's ataxia.
J L Bradley, J C Blake, S Chamberlain, P K Thomas, J M Cooper, A H Schapira. Hum Mol Genet 2000
268
11

Idebenone in Friedreich ataxia cardiomyopathy-results from a 6-month phase III study (IONIA).
Sarah J Lagedrost, Martin St John Sutton, Meryl S Cohen, Gary M Satou, Beth D Kaufman, Susan L Perlman, Christian Rummey, Thomas Meier, David R Lynch. Am Heart J 2011
81
13

Friedreich ataxia.
Massimo Pandolfo. Arch Neurol 2008
143
10

Friedreich ataxia: an overview.
M B Delatycki, R Williamson, S M Forrest. J Med Genet 2000
201
10

Idebenone and reduced cardiac hypertrophy in Friedreich's ataxia.
A O Hausse, Y Aggoun, D Bonnet, D Sidi, A Munnich, A Rötig, P Rustin. Heart 2002
177
10

The relationship between trinucleotide (GAA) repeat length and clinical features in Friedreich ataxia.
A Filla, G De Michele, F Cavalcanti, L Pianese, A Monticelli, G Campanella, S Cocozza. Am J Hum Genet 1996
391
10

Mouse models for Friedreich ataxia exhibit cardiomyopathy, sensory nerve defect and Fe-S enzyme deficiency followed by intramitochondrial iron deposits.
H Puccio, D Simon, M Cossée, P Criqui-Filipe, F Tiziano, J Melki, C Hindelang, R Matyas, P Rustin, M Koenig. Nat Genet 2001
530
10

Friedreich's ataxia: point mutations and clinical presentation of compound heterozygotes.
M Cossée, A Dürr, M Schmitt, N Dahl, P Trouillas, P Allinson, M Kostrzewa, A Nivelon-Chevallier, K H Gustavson, A Kohlschütter,[...]. Ann Neurol 1999
258
10

Idebenone treatment in Friedreich patients: one-year-long randomized placebo-controlled trial.
C Mariotti, A Solari, D Torta, L Marano, C Fiorentini, S Di Donato. Neurology 2003
149
10

Aconitase and mitochondrial iron-sulphur protein deficiency in Friedreich ataxia.
A Rötig, P de Lonlay, D Chretien, F Foury, M Koenig, D Sidi, A Munnich, P Rustin. Nat Genet 1997
767
10

The heart in Friedreich ataxia: definition of cardiomyopathy, disease severity, and correlation with neurological symptoms.
Frank Weidemann, Christian Rummey, Bart Bijnens, Stefan Störk, Ruta Jasaityte, Jan Dhooge, Aigul Baltabaeva, George Sutherland, Jörg B Schulz, Thomas Meier. Circulation 2012
77
11

FXN methylation predicts expression and clinical outcome in Friedreich ataxia.
Marguerite V Evans-Galea, Nissa Carrodus, Simone M Rowley, Louise A Corben, Geneieve Tai, Richard Saffery, John C Galati, Nicholas C Wong, Jeffrey M Craig, David R Lynch,[...]. Ann Neurol 2012
82
10



Clinical features of Friedreich's ataxia: classical and atypical phenotypes.
Michael H Parkinson, Sylvia Boesch, Wolfgang Nachbauer, Caterina Mariotti, Paola Giunti. J Neurochem 2013
130
9

Prolonged treatment with pimelic o-aminobenzamide HDAC inhibitors ameliorates the disease phenotype of a Friedreich ataxia mouse model.
Chiranjeevi Sandi, Ricardo Mouro Pinto, Sahar Al-Mahdawi, Vahid Ezzatizadeh, Glenn Barnes, Steve Jones, James R Rusche, Joel M Gottesfeld, Mark A Pook. Neurobiol Dis 2011
85
9

DNA methylation in intron 1 of the frataxin gene is related to GAA repeat length and age of onset in Friedreich ataxia patients.
I Castaldo, M Pinelli, A Monticelli, F Acquaviva, M Giacchetti, A Filla, S Sacchetti, S Keller, V E Avvedimento, L Chiariotti,[...]. J Med Genet 2008
70
11

Selective iron chelation in Friedreich ataxia: biologic and clinical implications.
Nathalie Boddaert, Kim Hanh Le Quan Sang, Agnès Rötig, Anne Leroy-Willig, Serge Gallet, Francis Brunelle, Daniel Sidi, Jean-Christophe Thalabard, Arnold Munnich, Z Ioav Cabantchik. Blood 2007
294
8


Idebenone treatment in Friedreich's ataxia: neurological, cardiac, and biochemical monitoring.
G Buyse, L Mertens, G Di Salvo, I Matthijs, F Weidemann, B Eyskens, W Goossens, N Goemans, G R Sutherland, J L K Van Hove. Neurology 2003
117
8

Progression characteristics of the European Friedreich's Ataxia Consortium for Translational Studies (EFACTS): a 2 year cohort study.
Kathrin Reetz, Imis Dogan, Ralf-Dieter Hilgers, Paola Giunti, Caterina Mariotti, Alexandra Durr, Sylvia Boesch, Thomas Klopstock, Francisco Javier Rodriguez de Rivera, Ludger Schöls,[...]. Lancet Neurol 2016
66
12

Clinical and genetic study of Friedreich ataxia in an Australian population.
M B Delatycki, D B Paris, R J Gardner, G A Nicholson, N Nassif, E Storey, J C MacMillan, V Collins, R Williamson, S M Forrest. Am J Med Genet 1999
96
7


Frataxin acts as an iron chaperone protein to modulate mitochondrial aconitase activity.
Anne-Laure Bulteau, Heather A O'Neill, Mary Claire Kennedy, Masao Ikeda-Saito, Grazia Isaya, Luke I Szweda. Science 2004
289
7

HDAC inhibitors correct frataxin deficiency in a Friedreich ataxia mouse model.
Myriam Rai, Elisabetta Soragni, Kai Jenssen, Ryan Burnett, David Herman, Giovanni Coppola, Daniel H Geschwind, Joel M Gottesfeld, Massimo Pandolfo. PLoS One 2008
161
7

Coenzyme Q10 and vitamin E deficiency in Friedreich's ataxia: predictor of efficacy of vitamin E and coenzyme Q10 therapy.
J M Cooper, L V P Korlipara, P E Hart, J L Bradley, A H V Schapira. Eur J Neurol 2008
108
7

Real time PCR quantification of frataxin mRNA in the peripheral blood leucocytes of Friedreich ataxia patients and carriers.
L Pianese, M Turano, M S Lo Casale, I De Biase, M Giacchetti, A Monticelli, C Criscuolo, A Filla, S Cocozza. J Neurol Neurosurg Psychiatry 2004
63
11

Measuring Friedreich ataxia: complementary features of examination and performance measures.
D R Lynch, J M Farmer, A Y Tsou, S Perlman, S H Subramony, C M Gomez, T Ashizawa, G R Wilmot, R B Wilson, L J Balcer. Neurology 2006
124
7

Antioxidant treatment of patients with Friedreich ataxia: four-year follow-up.
Paul E Hart, Raffaele Lodi, Bheeshma Rajagopalan, Jane L Bradley, Jenifer G Crilley, Christopher Turner, Andrew M Blamire, David Manners, Peter Styles, Anthony H V Schapira,[...]. Arch Neurol 2005
145
7

Clinical features of Friedreich ataxia.
Martin B Delatycki, Louise A Corben. J Child Neurol 2012
96
7

Increased iron in the dentate nucleus of patients with Friedrich's ataxia.
D Waldvogel, P van Gelderen, M Hallett. Ann Neurol 1999
166
6


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.